正子子断层扫描 (PET) 市场规模、份额、成长分析、按产品、按应用、按最终用户、按地区 - 产业预测，2024-2031 年

2022年全球正子断层扫描（PET）市场规模为23.5亿美元，在预测期内从2023年的25.2亿美元成长到2031年的42.1亿美元（预计复合年增长率为6.61%） 2024-2031 ）。

癌症和阿兹海默症危及生命的疾病的盛行率不断上升，极大地推动了对 PET 扫描的需求，这对于支持诊断和持续患者照护的先进成像技术至关重要。这些扫描提供了对体内生理和代谢过程的重要洞察，使医疗保健专业人员能够有效评估和管理慢性疾病，并最终改善患者的治疗效果和治疗效果。随着慢性病数量持续增加，对标靶治疗和个人化医疗的需求不断增加，使得 PET 扫描在根据患者的独特需求量身定制治疗方面具有不可估量的价值。由于分子成像技术的进步以及人工智慧 (AI) 和机器学习的结合提高了扫描的准确性和效率，这些成像技术已经发展到能够准确测量疾病进展和治疗反应。这些技术进步不仅将有助于更好地识别和追踪疾病状态，还将扩大 PET 扫描在各个医学专业的研究和临床诊断中的作用。因此，PET 扫描市场正在经历强劲成长，反映出 PET 扫描在现代医疗保健中的重要作用以及更个人化医疗方法的推动力。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 价值链分析
• 供应链分析
• 专利分析
• 贸易分析
• 技术分析
• 监管环境
• 案例研究分析

正子断层扫描市场：副产品

• 市场概况
• 独立 PET 系统
• PET/CT系统
  • 低切扫描仪
  • 中切扫描仪
  • 高切扫描仪
• PET/MRI系统

正子断层扫描市场：依应用分类

• 市场概况
• 肿瘤学
• 神经病学
• 心血管
• 其他用途

正子断层扫描市场：依最终用户分类

• 市场概况
• 医院和外科中心
• 诊断和影像诊所
• 门诊治疗中心
• 其他最终用户

正子断层扫描市场：按地区

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• General Electric
• Koninklijke Philips NV
• Siemens AG
• Shanghai United Imaging Healthcare Co., Ltd
• Canon Inc.
• Shimadzu Corporation
• Mediso Ltd.
• MinFound Medical Systems Co., Ltd
• Neusoft Corporation
• Bruker
• CMR Naviscan
• Kindsway Biotech
• Hermes Medical Solutions
• Sofie Biosciences
• Prescient Medical Imaging
• Reflexion
• Cubresa Inc.
• Synchropet, Inc.
• Novartis
• Revvity Inc.

Global Positron Emission Tomography Market size was valued at USD 2.35 billion in 2022 and is poised to grow from USD 2.52 billion in 2023 to USD 4.21 billion by 2031, growing at a CAGR of 6.61% during the forecast period (2024-2031).

The rising prevalence of life-threatening conditions like cancer and Alzheimer's disease has significantly fueled the demand for PET scans, which are essential for advanced imaging technologies that aid in diagnosis and ongoing patient care. These scans provide crucial insights into the physiological and metabolic processes within the body, enabling healthcare professionals to effectively assess and manage chronic conditions, ultimately improving patient outcomes and treatment success. As chronic illnesses continue to rise, there is an increasing need for targeted therapeutics and personalized medicine, making PET scans invaluable for tailoring treatments to unique patient needs. These imaging techniques have evolved to measure disease progression and therapeutic responses accurately, thanks to advancements in molecular imaging technology and the incorporation of artificial intelligence (AI) and machine learning, which enhance the precision and efficiency of scans. This technological evolution not only facilitates better identification and follow-up of medical conditions but also expands the role of PET scans in both research and clinical diagnostics across various medical specialties. Consequently, the market for PET scans is experiencing robust growth, reflecting their integral role in contemporary healthcare and the drive towards more personalized medical approaches.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Positron Emission Tomography market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Positron Emission Tomography Market Segmental Analysis

Global Positron Emission Tomography Market is segmented by Product, Application, End User, and Region. Based on Product, the market is segmented into Standalone PET Systems, PET/CT Systems (Low-Slice Scanners, Medium-Slice Scanners, High-Slice Scanners), PET/MRI Systems. Based on Application, the market is segmented into Oncology Applications, Neurological Applications, Cardiovascular Applications, Other Applications. Based on End User, the market is segmented into Hospitals & Surgical Centers, Diagnostic & Imaging Clinics, Ambulatory Care Centers, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Positron Emission Tomography Market

The escalating incidence of chronic diseases, including cancer, Alzheimer's disease, and cardiovascular disorders, serves as a pivotal market driver for the Global Positron Emission Tomography (PET) market. As these conditions necessitate sophisticated imaging techniques for effective diagnosis and ongoing management, PET scans have become vital tools in the healthcare arsenal. They provide critical insights into metabolic and physiological functions, which are essential for formulating tailored treatment plans. The burgeoning patient population suffering from chronic illnesses worldwide enhances the demand for PET technology, thereby propelling market growth. This trend underscores the need for advanced diagnostic modalities to effectively navigate the complexities of chronic disease management.

Restraints in the Global Positron Emission Tomography Market

The Global Positron Emission Tomography (PET) market faces significant restraints primarily due to the prohibitive costs associated with PET scanners. High purchase prices, coupled with substantial operational and maintenance expenses, pose hurdles for smaller medical facilities and diagnostic laboratories with limited budgets. This financial barrier restricts access to advanced imaging technologies, particularly in resource-constrained environments. As a result, the high costs hinder broader adoption and utilization of PET scanning services, ultimately stifling market growth and limiting the expansion of innovative applications that could enhance diagnostic capabilities and improve patient outcomes in the healthcare sector.

Market Trends of the Global Positron Emission Tomography Market

The Global Positron Emission Tomography (PET) market is experiencing significant growth driven by the integration of machine learning and artificial intelligence into scanning technologies. These advancements enhance image capture, reconstruction, and analysis, leading to improved diagnostic accuracy and expedited procedures. AI algorithms facilitate the detection of subtle anomalies and ensure precise tumor characterization, which translates into faster and more effective patient care. Furthermore, the utilization of machine learning to predict patient outcomes facilitates personalized treatment plans based on imaging data. As these technologies evolve, their incorporation into PET systems is poised to transform clinical and research practices, driving market expansion and accessibility.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Value Chain Analysis
• Supply Chain Analysis
• Patent Analysis
• Trade Analysis
• Technology Analysis
• Regulatory Landscape
• Case Study Analysis

Positron Emission Tomography Market, By Product

• Market Overview
• Standalone PET Systems
• PET/CT Systems
  • Low-Slice Scanners
  • Medium-Slice Scanners
  • High-Slice Scanners
• PET/MRI Systems

Positron Emission Tomography Market, By Application

• Market Overview
• Oncology Applications
• Neurological Applications
• Cardiovascular Applications
• Other Applications

Positron Emission Tomography Market, By End User

• Market Overview
• Hospitals And Surgical Centers
• Diagnostic And Imaging Clinics
• Ambulatory Care Centers
• Other End Users

Positron Emission Tomography Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• General Electric
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai United Imaging Healthcare Co., Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shimadzu Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mediso Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MinFound Medical Systems Co., Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neusoft Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CMR Naviscan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kindsway Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hermes Medical Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sofie Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prescient Medical Imaging
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reflexion
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cubresa Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synchropet, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments